Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Foltynie

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Progress in Brain Research|April 6, 2020
Repurposing anti-diabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experienceTom Foltynie, Dilan Athauda
Handbook of Clinical Neurology|September 28, 2024
Clinical/surgical considerationsTom Foltynie, Ludvic Zrinzo
Journal of Parkinson'S Disease|December 26, 2018
Therapies to Slow, Stop, or Reverse Parkinson's DiseaseTom Foltynie, J William Langston
Journal of Parkinson'S Disease|February 9, 2026
Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's diseaseTom Foltynie, Sonia Gandhi, Camille Carroll
Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2011
Deep brain stimulation in the treatment of choreaThomas C Edwards, Ludvic Zrinzo, Patricia Limousin, et al.
Parkinson'S Disease|July 5, 2018
Standardised Neuropsychological Assessment for the Selection of Patients Undergoing DBS for Parkinson's DiseaseJennifer A Foley, Tom Foltynie, Patricia Limousin, et al.
Neuropharmacology|August 23, 2020
Ropinirole, a dopamine agonist with high D<sub>3</sub> affinity, reduces proactive inhibition: A double-blind, placebo-controlled study in healthy adultsVishal Rawji, Lorenzo Rocchi, Tom Foltynie, et al.
Journal of Neurology|July 26, 2013
Successful pallidal deep brain stimulation in 15-year-old with Tourette syndrome: 2-year follow-upJoão Massano, Cláudia Sousa, Tom Foltynie, et al.
Clinical Parkinsonism & Related Disorders|July 28, 2021
The effects of deep brain stimulation of the pedunculopontine nucleus on cognition in Parkinson's disease and Progressive Supranuclear PalsyFriederike Leimbach, James Gratwicke, Tom Foltynie, et al.
Frontiers in Neurology|October 18, 2019
Dopaminergic Modulation of Sensory Attenuation in Parkinson's Disease: Is There an Underlying Modulation of Beta Power?Antonella Macerollo, Patricia Limousin, Prasad Korlipara, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Progress in Brain Research|April 6, 2020
Repurposing anti-diabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experienceTom Foltynie, Dilan Athauda
Handbook of Clinical Neurology|September 28, 2024
Clinical/surgical considerationsTom Foltynie, Ludvic Zrinzo
Journal of Parkinson'S Disease|December 26, 2018
Therapies to Slow, Stop, or Reverse Parkinson's DiseaseTom Foltynie, J William Langston
Journal of Parkinson'S Disease|February 9, 2026
Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's diseaseTom Foltynie, Sonia Gandhi, Camille Carroll
Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2011
Deep brain stimulation in the treatment of choreaThomas C Edwards, Ludvic Zrinzo, Patricia Limousin, et al.
Parkinson'S Disease|July 5, 2018
Standardised Neuropsychological Assessment for the Selection of Patients Undergoing DBS for Parkinson's DiseaseJennifer A Foley, Tom Foltynie, Patricia Limousin, et al.
Neuropharmacology|August 23, 2020
Ropinirole, a dopamine agonist with high D<sub>3</sub> affinity, reduces proactive inhibition: A double-blind, placebo-controlled study in healthy adultsVishal Rawji, Lorenzo Rocchi, Tom Foltynie, et al.
Journal of Neurology|July 26, 2013
Successful pallidal deep brain stimulation in 15-year-old with Tourette syndrome: 2-year follow-upJoão Massano, Cláudia Sousa, Tom Foltynie, et al.
Clinical Parkinsonism & Related Disorders|July 28, 2021
The effects of deep brain stimulation of the pedunculopontine nucleus on cognition in Parkinson's disease and Progressive Supranuclear PalsyFriederike Leimbach, James Gratwicke, Tom Foltynie, et al.
Frontiers in Neurology|October 18, 2019
Dopaminergic Modulation of Sensory Attenuation in Parkinson's Disease: Is There an Underlying Modulation of Beta Power?Antonella Macerollo, Patricia Limousin, Prasad Korlipara, et al.
Pageof 10